Ultrasound Findings of Finger, Wrist and Knee Joints in Mucopolysaccharidosis

NCT02067650 — Completed, 18 participants, Children's Hospital of Eastern Ontario

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT02067650
StatusCompleted
Study typeObservational
Enrollment18 (Actual)
SponsorChildren's Hospital of Eastern Ontario (Other)
ConditionsMPS I, MPS IV
Datesstart 2013-09-01, primary completion 2016-03-01, completion 2016-12-01, first posted 2014-02-20, last updated 2018-01-24
Locations1 site in Canada

Related Papers Related Patents Related Grants Related Experts
All trials for MPS I All trials for MPS IV

-Summary

Hardly any imaging studies specifically addressing the articular and periarticular structures in MPS patients are available at this point. The investigators propose to do for the first time a pilot study using musculoskeletal ultrasound in patients with various types of MPS.

Expand all sections  ·  Collapse all

+Outcome measures

Primary outcomes

  • Power Doppler [one time exam]: The primary objective is to determine whether patients with various types of MPS and at various stages of the disease exhibit abnormalities of the finger, wrist and knee joints as assessed by grey scale and Power Doppler ultrasonography.

Secondary outcomes

  • Ultrasound scanning technique [one time scan]: To determine the optimal ultrasound scanning technique for MPS patients given the potentially advanced joint contractures
  • Findings of synovitis or tenosynovitis [one time scan]: To determine whether there are ultrasound findings indicative of synovitis or tenosynovitis
  • Differences between MPS I and IV [one time scan]: To determine whether differences exist between MPS I and MPS IV
  • Differences between ERT and BMT [one time scan]: To determine whether differences exist between patients with or without Enzyme Replacement Therapy (ERT) or Bone Marrow Transplants
  • Differences between severe and attenuated phenotypes [one time scan]: To determine whether differences exist between severe and attenuated phenotypes

+Eligibility

Sex: All, ages: 2 Years to 99 Years

Inclusion Criteria

* Diagnosis of Mucopolysaccharidosis
* Ability to collaborate with the ultrasound assessment
* Written informed consent from parents and patients over 14 years of age, assent from children 7 to 14 years

Exclusion Criteria

* Inability to collaborate with the ultrasound assessment
* Acute trauma to a joint that will be assessed in the 3 months preceding the study
* Coexistence of other pathology that is known to affect the respective joints

+Locations (1)

FacilityCityCountryStatus
Children's Hospital of Eastern OntarioOttawa, OntarioCanada

+Investigators